| Variable | Boys (N = 60) | Girls (N = 60) | p value | Total (N = 120) |
|---|
| Age (years) | 11.9 (2.9) | 12.5 (3.5) | 0.363* | 12.2 (3.2) |
| Age at 1st diagnosis (years) | 5.1 (3.8) | 4.6 (3.5) | 0.435* | 4.9 (3.7) |
| Duration of ART treatment (years) | 6.6 (3.4) | 7.6 (4.2) | 0.98* | 7.0 (3.9) |
| Overall Age group: n (%) |
| School age | 11 (18.8) | 11 (18.3) | | 22 (18.3) |
| Early adolescence | 25 (41.7) | 33 (55.0) | | 58 (48.3) |
| Mid adolescence | 15 (25.0) | 11 (18.3) | | 26 (21.7) |
| Late adolescence | 9 (15.0) | 5 (8.3) | 0.472** | 14 (11.7) |
| School Attendance: n (%) | 60 (100) | 58 (96.7) | 0.476** | 118 (98.3) |
| On Antiretrovirals: n (%) | 59 (98.3) | 58 (96.7) | 0.559** | 117 (97.5) |
| Prevalence of disclosure: n (%) | 18 (30.0) | 25 (41.7) | 0.253** | 43 (35.8) |
| ∫Disclosure rate by age-group: n (%) |
| School age | 1 (9.1) | 2 (18.2) | | 3 (13.6) |
| Early adolescence | 3 (12.0) | 10 (30.3) | | 13 (22.4) |
| Mid adolescence | 6 (40.0) | 8 (72.7) | | 14 (53.8) |
| Late adolescence | 8 (88.9) | 5 (100) | 0.001** | 13 (92.9) |
| Who made disclosure: N = 43 n (%) |
| Mother alone | 7 (38.9) | 8 (32.0) | | 15 (34.9) |
| Father alone | 0 (0.0) | 5 (20.0) | | 5 (11.6) |
| Health worker | 4 (22.2) | 9 (36.0) | | 13 (30.2) |
| Grandmother | 2 (11.1) | 1 (4.0) | | 3 (7.0) |
| ¶Others | 5 (27.8) | 2 (8.0) | 0.212** | 7 (16.3) |
- Values presented as mean (SD), unless otherwise indicated, n (%) = Frequency (percentage), *Independent t-test p-values reported, **Chi-square p-values reported
- ∫Disclosure rate by age-group calculated based on overall number of children within each age group category (disclosed and non-disclosed)
- ¶Others: mother and father combined, Sister, Brother, Neighbour, Step-mother, Guardian, and unknown person
- School age (6–9 years), Early adolescence (10–13 years), Middle adolescence (14–16 years), Late adolescence (17–18 years) as described by Cromber et al. [17]
